{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:39:56Z","timestamp":1784637596636,"version":"3.55.0"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s12035-025-04806-8","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T17:57:17Z","timestamp":1741197437000},"page":"8809-8823","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Unlocking the Therapeutic Potential of the Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitors in Alzheimer\u2019s Diseases"],"prefix":"10.1007","volume":"62","author":[{"given":"Dipanjan","family":"Karati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyasi","family":"Meur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trina","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aratrika","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"4806_CR1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/archpsyc.63.2.168","volume":"63","author":"M Gatz","year":"2006","unstructured":"Gatz M et al (2006) Role of genes and environments for explainin Alzheimer disease. Arch Gen Psychiatry 63:168\u2013174","journal-title":"Arch Gen Psychiatry"},{"key":"4806_CR2","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D et al (2009) Genome - wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet 41:1088\u20131093","journal-title":"Nat Genet"},{"key":"4806_CR3","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert JC et al (2009) Genome - wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat Genet 41:1094\u20131099","journal-title":"Nat Genet"},{"key":"4806_CR4","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"S Seshadri","year":"2010","unstructured":"Seshadri S et al (2010) Genome,-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303:1832\u20131840","journal-title":"JAMA"},{"issue":"2","key":"4806_CR5","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.nbd.2005.03.020","volume":"20","author":"L Ferrer","year":"2005","unstructured":"Ferrer L, Barrachina M, Puig B, Martinez de Lagran M, Marti E, Avila J et al (2005) Constitutive DYRK1A is abnormally expressed in Alzheimer disease Down syndrome Pick disease and related transgenic models. Neurobiol Dis 20(2):392\u2013400. https:\/\/doi.org\/10.1016\/j.nbd.2005.03.020","journal-title":"Neurobiol Dis"},{"issue":"43","key":"4806_CR6","doi-asserted-by":"publisher","first-page":"39819","DOI":"10.1074\/jbc.M104091200]","volume":"276","author":"EJ Yang","year":"2001","unstructured":"Yang EJ, Ahn YS, Chung KC (2001) Protein kinase Dyrk1 activities cAMP response element-binding protein during neuronal differentiation in hippocampal progenitor cells. J Biol Chem 276(43):39819\u201339824. https:\/\/doi.org\/10.1074\/jbc.M104091200]","journal-title":"J Biol Chem"},{"key":"4806_CR7","first-page":"1","volume":"62","author":"W Becker","year":"1999","unstructured":"Becker W, Joost HG (1999) Structural and functional characteristics of Dyrk, a novel subfamily of protein kinases with dual specificity. Prog Nucleic Acid Res Mol Biol 62:1\u201317","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"issue":"2","key":"4806_CR8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1096\/fj.10-165837","volume":"25","author":"S Aranda","year":"2011","unstructured":"Aranda S, Laguna A, de la Luna S (2011) DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles. FASEB J 25(2):449\u2013462","journal-title":"FASEB J"},{"issue":"1","key":"4806_CR9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40478-010-0678-6","volume":"7","author":"B Souchet","year":"2019","unstructured":"Souchet B, Audrain M, Billard JM, Dairou J, Fol R, Orfeice NS et al (2019) Inhibition of DYRK1A proteolysis modifies its kinases specificity and rescues Alzheimer phenotype in APP PS1 mice. Acta Neuropathol Commun 7(1):46. https:\/\/doi.org\/10.1186\/s40478-010-0678-6","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"4806_CR10","doi-asserted-by":"publisher","first-page":"681","DOI":"10.4155\/fmc-2016-0013","volume":"8","author":"S Stotani","year":"2016","unstructured":"Stotani S, Giordanetto F, Medda F (2016) DYRK1A inhibiton as a potential treatment for Alzheimer\u2019s disease. Future Med Chem 8(6):681\u2013696. https:\/\/doi.org\/10.4155\/fmc-2016-0013","journal-title":"Future Med Chem"},{"issue":"12","key":"4806_CR11","doi-asserted-by":"publisher","first-page":"8364","DOI":"10.1007\/s12035-019-01684-9","volume":"56","author":"R Velazquez","year":"2019","unstructured":"Velazquez R, Meechoovet B, Ow A, Foley C, Shaw A, Smith B et al (2019) Chronic dyrk1 inhibition delays the onset of AD-like pathology in 3xTg-AD mice. Mol Neurobiol 56(12):8364\u20138375. https:\/\/doi.org\/10.1007\/s12035-019-01684-9","journal-title":"Mol Neurobiol"},{"issue":"2","key":"4806_CR12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrneurol.2009.218","volume":"6","author":"B De Strooper","year":"2010","unstructured":"De Strooper B, Vassar R, Golde T (2010) The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat Rev Neurol 6(2):99\u2013107","journal-title":"Nat Rev Neurol"},{"issue":"4\u20135","key":"4806_CR13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3233\/JAD-1999-14-512","volume":"1","author":"GV Johnson","year":"1999","unstructured":"Johnson GV, Hartigan JA (1999) Tau protein in normal and Alzheimer\u2019s disease brain: an update. J Alzheimers Dis JAD 1(4\u20135):329\u2013351","journal-title":"J Alzheimers Dis JAD"},{"issue":"3","key":"4806_CR14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/geno.1996.0636","volume":"38","author":"WJ Song","year":"1996","unstructured":"Song WJ, Sternberg LR, Kasten-Sport\u00e8s C et al (1996) Isolation of human and murine homologues of the Drosophila minibrain gene: human homologue maps to 21q22.2 in the Down syndrome \u201ccritical region.\u201d Genomics 38(3):331\u2013339","journal-title":"Genomics"},{"issue":"Pt 3","key":"4806_CR15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/bj3550609","volume":"355","author":"YL Woods","year":"2001","unstructured":"Woods YL, Cohen P, Becker W et al (2001) The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase. Biochem J 355(Pt 3):609\u2013615","journal-title":"Biochem J"},{"issue":"5","key":"4806_CR16","doi-asserted-by":"publisher","first-page":"e13000","DOI":"10.1111\/acel.13000","volume":"18","author":"B Melchior","year":"2019","unstructured":"Melchior B, Mittapalli GK, Lai C, Duong-Polk K, Stewart J, G\u00fcner B et al (2019) Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: a potential therapeutic for Alzheimer\u2019s disease. Aging Cell 18(5):e13000. https:\/\/doi.org\/10.1111\/acel.13000","journal-title":"Aging Cell"},{"key":"4806_CR17","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ejmech.2013.01.035","volume":"62","author":"G Burgy","year":"2013","unstructured":"Burgy G, Tahtouh T, Durieu E, Foll-Josselin B, Limanton E, Meijer L et al (2013) Chemical synthesis and biological validation of immobilized protein kinase inhibitory leucettines. Eur J Med Chem 62:728\u2013737. https:\/\/doi.org\/10.1016\/j.ejmech.2013.01.035","journal-title":"Eur J Med Chem"},{"issue":"59","key":"4806_CR18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejmech.2012.11.030","volume":"1","author":"Y Loidreau","year":"2013","unstructured":"Loidreau Y, Marchand P, Dubouilh-Benard C, Nourrisson MR, Duflos M, Loa\u00ebc N, Meijer L, Besson T (2013) Synthesis and biological evaluation of N-aryl-7-methoxybenzo [b] furo [3, 2-d] pyrimidin-4-amines and their N-arylbenzo [b] thieno [3, 2-d] pyrimidin-4-amine analogues as dual inhibitors of CLK1 and DYRK1A kinases. Eur J Med Chem 1(59):283\u2013295","journal-title":"Eur J Med Chem"},{"issue":"4","key":"4806_CR19","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.celrep.2013.03.027","volume":"3","author":"M Varjosalo","year":"2013","unstructured":"Varjosalo M, Keskitalo S, Van Drogen A, Nurkkala H, Vichalkovski A, Aebersold R, Gstaiger M (2013) The protein interaction landscape of the human CMGC kinase group. Cell Rep 3(4):1306\u20131320","journal-title":"Cell Rep"},{"issue":"9","key":"4806_CR20","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/hmg\/5.9.1305","volume":"5","author":"J Guimer\u00e1","year":"1996","unstructured":"Guimer\u00e1 J, Casas C, Pucharc\u00f2s C, Solans A, Dom\u00e8nech A, Planas AM, Ashley J, Lovett M et al (1996) A human homologue of Drosophila minibrain (MNB) is expressed in the neuronal regions affected in Down syndrome and maps to the critical region. Hum Mol Genet 5(9):1305\u20131310","journal-title":"Hum Mol Genet"},{"issue":"6784","key":"4806_CR21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/35012518","volume":"405","author":"M Hattori","year":"2000","unstructured":"Hattori M, Fujiyama A, Taylor TD, Watanabe H, Yada T, Park HS, Toyoda A, Ishii K et al (2000) The DNA sequence of human chromosome 21. Nature 405(6784):311\u2013319","journal-title":"Nature"},{"issue":"2","key":"4806_CR22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/ng1095-126","volume":"11","author":"N Patil","year":"1995","unstructured":"Patil N, Cox DR, Bhat D, Faham M, Myers RM, Peterson AS (1995) A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation. Nat Genet 11(2):126\u2013129","journal-title":"Nat Genet"},{"issue":"1","key":"4806_CR23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s41398-023-02419-0","volume":"13","author":"JM Delabar","year":"2023","unstructured":"Delabar JM, Lagarde J, Fructuoso M, Mohammad A, Bottlaender M, Doran E, Lott I, Rivals I et al (2023) Increased plasma DYRK1A with aging may protect against neurodegenerative diseases. Transl Psychiatry 13(1):111","journal-title":"Transl Psychiatry"},{"issue":"158","key":"4806_CR24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ejmech.2018.08.093","volume":"5","author":"A Pathak","year":"2018","unstructured":"Pathak A, Rohilla A, Gupta T, Akhtar MJ, Haider MR, Sharma K, Haider K, Yar MS (2018) DYRK1A kinase inhibition with emphasis on neurodegeneration: a comprehensive evolution story-cum-perspective. Eur J Med Chem 5(158):559\u2013592","journal-title":"Eur J Med Chem"},{"issue":"7","key":"4806_CR25","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1074\/jbc.271.7.3488","volume":"271","author":"H Kentrup","year":"1996","unstructured":"Kentrup H, Becker W, Heukelbach J, Wilmes A, Sch\u00fcrmann A, Huppertz C, Kainulainen H, Joost HG (1996) DYRK, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII (\u2217). J Biol Chem 271(7):3488\u20133495","journal-title":"J Biol Chem"},{"issue":"5","key":"4806_CR26","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1107\/S1399004715005106","volume":"71","author":"M Alexeeva","year":"2015","unstructured":"Alexeeva M, \u00c5berg E, Engh RA, Rothweiler U (2015) The structure of a dual-specificity tyrosine phosphorylation-regulated kinase 1A\u2013PKC412 complex reveals disulfide-bridge formation with the anomalous catalytic loop HRD (HCD) cysteine. Acta Crystallogr D Biol Crystallogr 71(5):1207\u20131215","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"24","key":"4806_CR27","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1016\/j.bmcl.2013.10.055","volume":"23","author":"K Anderson","year":"2013","unstructured":"Anderson K, Chen Y, Chen Z, Dominique R, Glenn K, He Y, Janson C, Luk KC et al (2013) Pyrido [2, 3-d] pyrimidines: discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors. Bioorg Med Chem Lett 23(24):6610\u20136615","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"4806_CR28","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1021\/jm501994d","volume":"58","author":"H Falke","year":"2015","unstructured":"Falke H, Chaikuad A, Becker A, Loa\u00ebc N, Lozach O, Abu Jhaisha S, Becker W, Jones PG et al (2015) 10-Iodo-11 H-indolo [3, 2-c] quinoline-6-carboxylic acids are selective inhibitors of DYRK1A. J Med Chem 58(7):3131\u20133143","journal-title":"J Med Chem"},{"issue":"1","key":"4806_CR29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ncomms1090","volume":"1","author":"Y Ogawa","year":"2010","unstructured":"Ogawa Y, Nonaka Y, Goto T, Ohnishi E, Hiramatsu T, Kii I, Yoshida M, Ikura T et al (2010) Development of a novel selective inhibitor of the Down syndrome-related kinase DYRK1A. Nat Commun 1(1):86","journal-title":"Nat Commun"},{"issue":"21","key":"4806_CR30","doi-asserted-by":"crossref","first-page":"9814","DOI":"10.1021\/acs.jmedchem.6b01086","volume":"59","author":"U Rothweiler","year":"2016","unstructured":"Rothweiler U, Stensen W, Brandsdal BO, Isaksson J, Leeson FA, Engh RA, Svendsen JS (2016) Probing the ATP-binding pocket of protein kinase DYRK1A with benzothiazole fragment molecules. J Med Chem 59(21):9814\u20139824","journal-title":"J Med Chem"},{"issue":"21","key":"4806_CR31","doi-asserted-by":"crossref","first-page":"9312","DOI":"10.1021\/jm301034u","volume":"55","author":"T Tahtouh","year":"2012","unstructured":"Tahtouh T, Elkins JM, Filippakopoulos P, Soundararajan M, Burgy G, Durieu E, Cochet C, Schmid RS et al (2012) Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B. J Med Chem 55(21):9312\u20139330","journal-title":"J Med Chem"},{"issue":"7","key":"4806_CR32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0968-0004(96)10031-1","volume":"21","author":"M Rechsteiner","year":"1996","unstructured":"Rechsteiner M, Rogers SW (1996) PEST sequences and regulation by proteolysis. Trends Biochem Sci 21(7):267\u2013271","journal-title":"Trends Biochem Sci"},{"issue":"4","key":"4806_CR33","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.biocel.2004.12.006","volume":"37","author":"M Bescond","year":"2005","unstructured":"Bescond M, Rahmani Z (2005) Dual-specificity tyrosine-phosphorylated and regulated kinase 1A (DYRK1A) interacts with the phytanoyl-CoA \u03b1-hydroxylase associated protein 1 (PAHX-AP1), a brain specific protein. Int J Biochem Cell Biol 37(4):775\u2013783","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"4806_CR34","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1006\/bbrc.1998.9967","volume":"254","author":"S Leder","year":"1999","unstructured":"Leder S, Weber Y, Altafaj X, Estivill X, Joost HG, Becker W (1999) Cloning and characterization of DYRK1B, a novel member of the DYRK family of protein kinases. Biochemical and biophysical research communications 254(2):474\u20139","journal-title":"Biochemical and biophysical research communications"},{"issue":"2","key":"4806_CR35","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1742-4658.2010.07956.x","volume":"278","author":"W Becker","year":"2011","unstructured":"Becker W, Sippl W (2011) Activation, regulation, and inhibition of DYRK1A. FEBS J 278(2):246\u2013256","journal-title":"FEBS J"},{"issue":"3","key":"4806_CR36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1042\/bj3590497","volume":"359","author":"S Himpel","year":"2001","unstructured":"Himpel S, Panzer P, Eirmbter K, Czajkowska H, Sayed M, Packman LC, Blundell T, Kentrup H et al (2001) Identification of the autophosphorylation sites and characterization of their effects in the protein kinase DYRK1A. Biochem J 359(3):497\u2013505","journal-title":"Biochem J"},{"issue":"6","key":"4806_CR37","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.cell.2005.03.034","volume":"121","author":"PA Lochhead","year":"2005","unstructured":"Lochhead PA, Sibbet G, Morrice N, Cleghon V (2005) Activation-loop autophosphorylation is mediated by a novel transitional intermediate form of DYRKs. Cell 121(6):925\u2013936","journal-title":"Cell"},{"issue":"21","key":"4806_CR38","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1111\/j.1742-4658.2009.07346.x","volume":"276","author":"N G\u00f6ckler","year":"2009","unstructured":"G\u00f6ckler N, Jofre G, Papadopoulos C, Soppa U, Tejedor FJ, Becker W (2009) Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation. FEBS J 276(21):6324\u20136337","journal-title":"FEBS J"},{"issue":"25","key":"4806_CR39","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1021\/bi700251n","volume":"46","author":"T Adayev","year":"2007","unstructured":"Adayev T, Chen-Hwang MC, Murakami N, Lee E, Bolton DC, Hwang YW (2007) Dual-specificity tyrosine phosphorylation-regulated kinase 1A does not require tyrosine phosphorylation for activity in vitro. Biochemistry 46(25):7614\u20137624","journal-title":"Biochemistry"},{"issue":"1","key":"4806_CR40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ab.2010.02.016","volume":"401","author":"L Munoz","year":"2010","unstructured":"Munoz L, Selig R, Yeung YT, Peifer C, Hauser D, Laufer S (2010) Fluorescence polarization binding assay to develop inhibitors of inactive p38\u03b1 mitogen-activated protein kinase. Anal Biochem 401(1):125\u2013133","journal-title":"Anal Biochem"},{"issue":"4","key":"4806_CR41","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1091\/mbc.e06-08-0668","volume":"18","author":"M Alvarez","year":"2007","unstructured":"Alvarez M, Altafaj X, Aranda S, de la Luna S (2007) DYRK1A autophosphorylation on serine residue 520 modulates its kinase activity via 14-3-3 binding. Mol Biol Cell 18(4):1167\u20131178","journal-title":"Mol Biol Cell"},{"issue":"2","key":"4806_CR42","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jnr.23279","volume":"92","author":"W Kaczmarski","year":"2014","unstructured":"Kaczmarski W, Barua M, Mazur-Kolecka B, Frackowiak J, Dowjat W, Mehta P, Bolton D, Hwang YW et al (2014) Intracellular distribution of differentially phosphorylated dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A). J Neurosci Res 92(2):162\u2013173","journal-title":"J Neurosci Res"},{"issue":"4","key":"4806_CR43","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1074\/jbc.275.4.2431","volume":"275","author":"S Himpel","year":"2000","unstructured":"Himpel S, Tegge W, Frank R, Leder S, Joost HG, Becker W (2000) Specificity determinants of substrate recognition by the protein kinase DYRK1A. J Biol Chem 275(4):2431\u20132438","journal-title":"J Biol Chem"},{"issue":"6","key":"4806_CR44","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.str.2013.03.012","volume":"21","author":"M Soundararajan","year":"2013","unstructured":"Soundararajan M, Roos AK, Savitsky P, Filippakopoulos P, Kettenbach AN, Olsen JV, Gerber SA, Eswaran J et al (2013) Structures of Down syndrome kinases, DYRKs, reveal mechanisms of kinase activation and substrate recognition. Structure 21(6):986\u2013996","journal-title":"Structure"},{"issue":"48","key":"4806_CR45","doi-asserted-by":"crossref","first-page":"34850","DOI":"10.1074\/jbc.M707358200","volume":"282","author":"SR Ryoo","year":"2007","unstructured":"Ryoo SR, Jeong HK, Radnaabazar C, Yoo JJ, Cho HJ, Lee HW, Kim IS, Cheon YH et al (2007) DYRK1A-mediated hyperphosphorylation of tau. J Biol Chem 282(48):34850\u201334857","journal-title":"J Biol Chem"},{"issue":"24","key":"4806_CR46","doi-asserted-by":"crossref","first-page":"6268","DOI":"10.1111\/j.1742-4658.2008.06751.x","volume":"275","author":"A Seifert","year":"2008","unstructured":"Seifert A, Allan LA, Clarke PR (2008) DYRK1A phosphorylates caspase 9 at an inhibitory site and is potently inhibited in human cells by harmine. FEBS J 275(24):6268\u20136280","journal-title":"FEBS J"},{"key":"4806_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2091-7-7","volume":"7","author":"K de Graaf","year":"2006","unstructured":"de Graaf K, Czajkowska H, Rottmann S, Packman LC, Lilischkis R, L\u00fcscher B, Becker W (2006) The protein kinase DYRK1A phosphorylates the splicing factor SF3b1\/SAP155 at Thr434, a novel in vivo phosphorylation site. BMC Biochem 7:1\u20133","journal-title":"BMC Biochem"},{"issue":"44","key":"4806_CR48","doi-asserted-by":"crossref","first-page":"33250","DOI":"10.1074\/jbc.M606147200","volume":"281","author":"EJ Kim","year":"2006","unstructured":"Kim EJ, Sung JY, Lee HJ, Rhim H, Hasegawa M, Iwatsubo T, Kim J, Paik SR et al (2006) DYRK1A phosphorylates \u03b1-synuclein and enhances intracellular inclusion formation. J Biol Chem 281(44):33250\u201333257","journal-title":"J Biol Chem"},{"issue":"41","key":"4806_CR49","doi-asserted-by":"crossref","first-page":"31895","DOI":"10.1074\/jbc.M110.147520","volume":"285","author":"J Park","year":"2010","unstructured":"Park J, Oh Y, Yoo L, Jung MS, Song WJ, Lee SH, Seo H, Chung KC (2010) DYRK1A phosphorylates p53 and inhibits proliferation of embryonic neuronal cells. J Biol Chem 285(41):31895\u201331906","journal-title":"J Biol Chem"},{"issue":"10","key":"4806_CR50","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/brainsci8100187","volume":"8","author":"A Feki","year":"2018","unstructured":"Feki A, Hibaoui Y (2018) DYRK1A protein, a promising therapeutic target to improve cognitive deficits in Down syndrome. Brain Sci 8(10):187","journal-title":"Brain Sci"},{"issue":"151","key":"4806_CR51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pharmthera.2015.03.004","volume":"1","author":"R Abbassi","year":"2015","unstructured":"Abbassi R, Johns TG, Kassiou M, Munoz L (2015) DYRK1A in neurodegeneration and cancer: molecular basis and clinical implications. Pharmacol Ther 1(151):87\u201398","journal-title":"Pharmacol Ther"},{"issue":"8","key":"4806_CR52","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/embor.2011.98","volume":"12","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Liao JM, Zeng SX, Lu H (2011) p53 downregulates Down syndrome-associated DYRK1A through miR-1246. EMBO Rep 12(8):811\u2013817","journal-title":"EMBO Rep"},{"issue":"12","key":"4806_CR53","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/ncb2126","volume":"12","author":"PA da Costa Martins","year":"2010","unstructured":"da Costa Martins PA, Salic K, Gladka MM, Armand AS, Leptidis S, El Azzouzi H, Hansen A, Coenen-de Roo CJ et al (2010) MicroRNA-199b targets the nuclear kinase DYRK1A in an auto-amplification loop promoting calcineurin\/NFAT signalling. Nat Cell Biol 12(12):1220\u20131227","journal-title":"Nat Cell Biol"},{"issue":"35","key":"4806_CR54","doi-asserted-by":"crossref","first-page":"13074","DOI":"10.1073\/pnas.0601915103","volume":"103","author":"MY Kim","year":"2006","unstructured":"Kim MY, Jeong BC, Lee JH, Kee HJ, Kook H, Kim NS, Kim YH, Kim JK et al (2006) A repressor complex, AP4 transcription factor and geminin, negatively regulates expression of target genes in nonneuronal cells. Proc Natl Acad Sci 103(35):13074\u201313079","journal-title":"Proc Natl Acad Sci"},{"issue":"7093","key":"4806_CR55","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nature04678","volume":"441","author":"JR Arron","year":"2006","unstructured":"Arron JR, Winslow MM, Polleri A, Chang CP, Wu H, Gao X, Neilson JR, Chen L et al (2006) NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441(7093):595\u2013600","journal-title":"Nature"},{"issue":"48","key":"4806_CR56","doi-asserted-by":"crossref","first-page":"33343","DOI":"10.1074\/jbc.M109.042234","volume":"284","author":"Y Lee","year":"2009","unstructured":"Lee Y, Ha J, Kim HJ, Kim YS, Chang EJ, Song WJ, Kim HH (2009) Negative feedback inhibition of NFATc1 by DYRK1A regulates bone homeostasis. J Biol Chem 284(48):33343\u201333351","journal-title":"J Biol Chem"},{"issue":"7093","key":"4806_CR57","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nature04631","volume":"441","author":"Y Gwack","year":"2006","unstructured":"Gwack Y, Sharma S, Nardone J, Tanasa B, Iuga A, Srikanth S, Okamura H, Bolton D et al (2006) A genome-wide Drosophila RNAi screen identifies DYRK-family kinases as regulators of NFAT. Nature 441(7093):646\u2013650","journal-title":"Nature"},{"issue":"3","key":"4806_CR58","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/bj3550609","volume":"355","author":"YL Woods","year":"2001","unstructured":"Woods YL, Cohen P, Becker W, Jakes R, Goedert M, Wang X, Proud CG (2001) The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2B\u025b at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase. Biochem J 355(3):609\u2013615","journal-title":"Biochem J"},{"issue":"12","key":"4806_CR59","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nrn3314","volume":"13","author":"M Dierssen","year":"2012","unstructured":"Dierssen M (2012) Down syndrome: the brain in trisomic mode. Nat Rev Neurosci 13(12):844\u2013858","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"4806_CR60","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1101\/gad.377106","volume":"20","author":"L Nguyen","year":"2006","unstructured":"Nguyen L, Besson A, Heng JI, Schuurmans C, Teboul L, Parras C, Philpott A, Roberts JM et al (2006) p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes Dev 20(11):1511\u20131524","journal-title":"Genes Dev"},{"issue":"12","key":"4806_CR61","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1242\/dev.066167","volume":"138","author":"B H\u00e4mmerle","year":"2011","unstructured":"H\u00e4mmerle B, Ulin E, Guimera J, Becker W, Guillemot F, Tejedor FJ (2011) Transient expression of Mnb\/DYRK1A couples cell cycle exit and differentiation of neuronal precursors by inducing p27KIP1 expression and suppressing NOTCH signaling. Development 138(12):2543\u20132554","journal-title":"Development"},{"issue":"8","key":"4806_CR62","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1101\/gad.2034211","volume":"25","author":"L Litovchick","year":"2011","unstructured":"Litovchick L, Florens LA, Swanson SK, Washburn MP, DeCaprio JA (2011) DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly. Genes Dev 25(8):801\u2013813","journal-title":"Genes Dev"},{"issue":"2","key":"4806_CR63","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1006\/dbio.2000.0110","volume":"230","author":"J Ceron","year":"2001","unstructured":"Ceron J, Gonz\u00e1lez C, Tejedor FJ (2001) Patterns of cell division and expression of asymmetric cell fate determinants in postembryonic neuroblast lineages of Drosophila. Dev Biol 230(2):125\u2013138","journal-title":"Dev Biol"},{"issue":"17","key":"4806_CR64","first-page":"3195","volume":"143","author":"MN Shaikh","year":"2016","unstructured":"Shaikh MN, Gutierrez-Avino F, Colonques J, Ceron J, H\u00e4mmerle B, Tejedor FJ (2016) Minibrain drives the Dacapo-dependent cell cycle exit of neurons in the Drosophila brain by promoting asense and prospero expression. Development 143(17):3195\u20133205","journal-title":"Development"},{"issue":"13","key":"4806_CR65","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.4161\/cc.29104","volume":"13","author":"U Soppa","year":"2014","unstructured":"Soppa U, Schumacher J, Florencio Ortiz V, Pasqualon T, Tejedor F, Becker W (2014) The Down syndrome-related protein kinase DYRK1A phosphorylates p27Kip1 and cyclin D1 and induces cell cycle exit and neuronal differentiation. Cell Cycle 13(13):2084\u20132100","journal-title":"Cell Cycle"},{"issue":"11","key":"4806_CR66","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1523\/JNEUROSCI.4711-09.2010","volume":"30","author":"O Yabut","year":"2010","unstructured":"Yabut O, Domogauer J, D\u2019Arcangelo G (2010) DYRK1A overexpression inhibits proliferation and induces premature neuronal differentiation of neural progenitor cells. J Neurosci 30(11):4004\u20134014","journal-title":"J Neurosci"},{"issue":"2","key":"4806_CR67","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ebiom.2015.01.010","volume":"2","author":"S Najas","year":"2015","unstructured":"Najas S, Arranz J, Lochhead PA, Ashford AL, Oxley D, Delabar JM, Cook SJ, Barallobre MJ et al (2015) DYRK1A-mediated cyclin D1 degradation in neural stem cells contributes to the neurogenic cortical defects in Down syndrome. EBioMedicine 2(2):120\u2013134","journal-title":"EBioMedicine"},{"issue":"24","key":"4806_CR68","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1101\/gad.226381.113","volume":"27","author":"N Kurabayashi","year":"2013","unstructured":"Kurabayashi N, Sanada K (2013) Increased dosage of DYRK1A and DSCR1 delays neuronal differentiation in neocortical progenitor cells. Genes Dev 27(24):2708\u20132721","journal-title":"Genes Dev"},{"key":"4806_CR69","doi-asserted-by":"crossref","unstructured":"Sanapathi J, Vipparthi P, Mishra S, Sosnik A, Kumarasamy M (2023) Microfluidics for brain endothelial cell-astrocyte interactions. Organs-on-a-Chip 1(5):100033","DOI":"10.1016\/j.ooc.2023.100033"},{"issue":"18","key":"4806_CR70","doi-asserted-by":"crossref","first-page":"6636","DOI":"10.1128\/MCB.22.18.6636-6647.2002","volume":"22","author":"V Fotaki","year":"2002","unstructured":"Fotaki V, Dierssen M, Alc\u00e1ntara S, Mart\u00ednez S, Mart\u00ed E, Casas C, Visa J, Soriano E et al (2002) DYRK1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice. Mol Cell Biol 22(18):6636\u20136647","journal-title":"Mol Cell Biol"},{"issue":"1","key":"4806_CR71","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.nbd.2012.01.007","volume":"46","author":"F Guedj","year":"2012","unstructured":"Guedj F, Pereira PL, Najas S, Barallobre MJ, Chabert C, Souchet B, Sebrie C, Verney C et al (2012) DYRK1A: a master regulatory protein controlling brain growth. Neurobiol Dis 46(1):190\u2013203","journal-title":"Neurobiol Dis"},{"issue":"9","key":"4806_CR72","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nrn3767","volume":"15","author":"C Cepko","year":"2014","unstructured":"Cepko C (2014) Intrinsically different retinal progenitor cells produce specific types of progeny. Nat Rev Neurosci 15(9):615\u2013627","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"4806_CR73","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.devcel.2008.10.014","volume":"15","author":"A Laguna","year":"2008","unstructured":"Laguna A, Aranda S, Barallobre MJ, Barhoum R, Fern\u00e1ndez E, Fotaki V, Delabar JM, de la Luna S et al (2008) The protein kinase DYRK1A regulates caspase-9-mediated apoptosis during retina development. Devel Cell 15(6):841\u2013853","journal-title":"Devel Cell"},{"issue":"6","key":"4806_CR74","doi-asserted-by":"crossref","first-page":"e1289","DOI":"10.1038\/cddis.2014.253","volume":"5","author":"MJ Barallobre","year":"2014","unstructured":"Barallobre MJ, Perier C, Bov\u00e9 J, Laguna A, Delabar JM, Vila M, Arbon\u00e9s ML (2014) DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson\u2019s disease. Cell Death Dis 5(6):e1289","journal-title":"Cell Death Dis"},{"issue":"6","key":"4806_CR75","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/cge.13038","volume":"92","author":"YM Kim","year":"2017","unstructured":"Kim YM, Lee YJ, Park JH, Lee HD, Cheon CK, Kim SY, Hwang JY, Jang JH et al (2017) High diagnostic yield of clinically unidentifiable syndromic growth disorders by targeted exome sequencing. Clin Genet 92(6):594\u2013605","journal-title":"Clin Genet"},{"issue":"1","key":"4806_CR76","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0959-4388(99)80010-5","volume":"9","author":"JR Sanes","year":"1999","unstructured":"Sanes JR, Yamagata M (1999) Formation of lamina-specific synaptic connections. Curr Opin Neurobiol 9(1):79\u201387","journal-title":"Curr Opin Neurobiol"},{"issue":"19","key":"4806_CR77","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1128\/MCB.00394-08","volume":"28","author":"S Aranda","year":"2008","unstructured":"Aranda S, Alvarez M, Turr\u00f3 S, Laguna A, de la Luna S (2008) Sprouty2-mediated inhibition of fibroblast growth factor signaling is modulated by the protein kinase DYRK1A. Mol Cell Biol 28(19):5899\u20135911","journal-title":"Mol Cell Biol"},{"issue":"10","key":"4806_CR78","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1242\/dev.115568","volume":"142","author":"A Dabrowski","year":"2015","unstructured":"Dabrowski A, Terauchi A, Strong C, Umemori H (2015) Distinct sets of FGF receptors sculpt excitatory and inhibitory synaptogenesis. Development 142(10):1818\u20131830","journal-title":"Development"},{"issue":"6","key":"4806_CR79","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.neuron.2006.04.030","volume":"50","author":"R Shirasaki","year":"2006","unstructured":"Shirasaki R, Lewcock JW, Lettieri K, Pfaff SL (2006) FGF as a target-derived chemoattractant for developing motor axons genetically programmed by the LIM code. Neuron 50(6):841\u2013853","journal-title":"Neuron"},{"issue":"87","key":"4806_CR80","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0070-2153(09)01202-2","volume":"1","author":"DA Col\u00f3n-Ramos","year":"2009","unstructured":"Col\u00f3n-Ramos DA (2009) Synapse formation in developing neural circuits. Curr Top Dev Biol 1(87):53\u201379","journal-title":"Curr Top Dev Biol"},{"issue":"12","key":"4806_CR81","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/NEN.0b013e31827733c8","volume":"71","author":"K Dowjat","year":"2012","unstructured":"Dowjat K, Adayev T, Kaczmarski W, Wegiel J, Hwang YW (2012) Gene dosage-dependent association of DYRK1A with the cytoskeleton in the brain and lymphocytes of Down syndrome patients. J Neuropathol Exp Neurol 71(12):1100\u20131112","journal-title":"J Neuropathol Exp Neurol"},{"issue":"9","key":"4806_CR82","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1096\/fj.07-104539","volume":"22","author":"F Liu","year":"2008","unstructured":"Liu F, Liang Z, Wegiel J, Hwang YW, Iqbal K, Grundke-Iqbal I, Ramakrishna N, Gong CX (2008) Overexpression of DYRK1A contributes to neurofibrillary degeneration in Down syndrome. FASEB J 22(9):3224","journal-title":"FASEB J"},{"issue":"12","key":"4806_CR83","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/cercor\/bhr362","volume":"22","author":"M de Martinez Lagran","year":"2012","unstructured":"de Martinez Lagran M, Benavides-Piccione R, Ballesteros-Ya\u00f1ez I, Calvo M, Morales M, Fillat C, Defelipe J, Ramakers GJ et al (2012) DYRK1A influences neuronal morphogenesis through regulation of cytoskeletal dynamics in mammalian cortical neurons. Cereb Cortex 22(12):2867\u20132877","journal-title":"Cereb Cortex"},{"issue":"1","key":"4806_CR84","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1242\/jcs.086124","volume":"125","author":"J Park","year":"2012","unstructured":"Park J, Sung JY, Park J, Song WJ, Chang S, Chung KC (2012) DYRK1A negatively regulates the actin cytoskeleton through threonine phosphorylation of N-WASP. J Cell Sci 125(1):67\u201380","journal-title":"J Cell Sci"},{"issue":"14","key":"4806_CR85","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1242\/jcs.040162","volume":"122","author":"TM Scales","year":"2009","unstructured":"Scales TM, Lin S, Kraus M, Goold RG, Gordon-Weeks PR (2009) Nonprimed and DYRK1A-primed GSK3\u03b2-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons. J Cell Sci 122(14):2424\u20132435","journal-title":"J Cell Sci"},{"key":"4806_CR86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2009-10-1-r1","volume":"10","author":"T Liu","year":"2009","unstructured":"Liu T, Sims D, Baum B (2009) Parallel RNAi screens across different cell lines identify generic and cell type-specific regulators of actin organization and cell morphology. Genome Biol 10:1\u20139","journal-title":"Genome Biol"},{"issue":"3","key":"4806_CR87","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.neuron.2016.03.027","volume":"90","author":"KM Ori-McKenney","year":"2016","unstructured":"Ori-McKenney KM, McKenney RJ, Huang HH, Li T, Meltzer S, Jan LY, Vale RD, Wiita AP et al (2016) Phosphorylation of \u03b2-tubulin by the Down syndrome kinase, minibrain\/DYRK1A, regulates microtubule dynamics and dendrite morphogenesis. Neuron 90(3):551\u2013563","journal-title":"Neuron"},{"issue":"5","key":"4806_CR88","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1471-4159.2007.05075.x","volume":"104","author":"SR Ryoo","year":"2008","unstructured":"Ryoo SR, Cho HJ, Lee HW, Jeong HK, Radnaabazar C, Kim YS, Kim MJ, Son MY et al (2008) Dual-specificity tyrosine (Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer\u2019s disease. J Neurochem 104(5):1333\u20131344","journal-title":"J Neurochem"},{"issue":"1","key":"4806_CR89","doi-asserted-by":"crossref","first-page":"e54285","DOI":"10.1371\/journal.pone.0054285","volume":"8","author":"G Arque","year":"2013","unstructured":"Arque G, Casanovas A, Dierssen M (2013) DYRK1A is dynamically expressed on subsets of motor neurons and in the neuromuscular junction: possible role in Down syndrome. PLoS ONE 8(1):e54285","journal-title":"PLoS ONE"},{"issue":"1","key":"4806_CR90","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1038\/ncomms5246","volume":"5","author":"CK Chen","year":"2014","unstructured":"Chen CK, Bregere C, Paluch J, Lu JF, Dickman DK, Chang KT (2014) Activity-dependent facilitation of synaptojanin and synaptic vesicle recycling by the minibrain kinase. Nat Commun 5(1):4246","journal-title":"Nat Commun"},{"issue":"3","key":"4806_CR91","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000321994","volume":"18","author":"Y Kim","year":"2011","unstructured":"Kim Y, Park J, Song WJ, Chang S (2011) Overexpression of DYRK1A causes the defects in synaptic vesicle endocytosis. Neurosignals 18(3):164\u2013172","journal-title":"Neurosignals"},{"issue":"22","key":"4806_CR92","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1523\/JNEUROSCI.3804-15.2016","volume":"36","author":"F Fan","year":"2016","unstructured":"Fan F, Funk L, Lou X (2016) Dynamin 1-and 3-mediated endocytosis is essential for the development of a large central synapse in vivo. J Neurosci 36(22):6097\u20136115","journal-title":"J Neurosci"},{"issue":"4","key":"4806_CR93","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0955-0674(98)80066-5","volume":"10","author":"SL Schmid","year":"1998","unstructured":"Schmid SL, McNiven MA, De Camilli P (1998) Dynamin and its partners: a progress report. Curr Opin Cell Biol 10(4):504\u2013512","journal-title":"Curr Opin Cell Biol"},{"issue":"33","key":"4806_CR94","doi-asserted-by":"crossref","first-page":"23712","DOI":"10.1074\/jbc.M513497200","volume":"281","author":"N Murakami","year":"2006","unstructured":"Murakami N, Xie W, Lu RC, Chen-Hwang MC, Wieraszko A, Hwang YW (2006) Phosphorylation of amphiphysin I by minibrain kinase\/dual-specificity tyrosine phosphorylation-regulated kinase, a kinase implicated in Down syndrome. J Biol Chem 281(33):23712\u201323724","journal-title":"J Biol Chem"},{"issue":"39","key":"4806_CR95","doi-asserted-by":"crossref","first-page":"9297","DOI":"10.1021\/bi9010557","volume":"48","author":"N Murakami","year":"2009","unstructured":"Murakami N, Bolton D, Hwang YW (2009) DYRK1A binds to multiple endocytic proteins required for formation of clathrin-coated vesicles. Biochemistry 48(39):9297\u20139305","journal-title":"Biochemistry"},{"issue":"4","key":"4806_CR96","doi-asserted-by":"crossref","first-page":"e34845","DOI":"10.1371\/journal.pone.0034845","volume":"7","author":"N Murakami","year":"2012","unstructured":"Murakami N, Bolton DC, Kida E, Xie W, Hwang YW (2012) Phosphorylation by DYRK1A of clathrin coated vesicle-associated proteins: identification of the substrate proteins and the effects of phosphorylation. PLoS ONE 7(4):e34845","journal-title":"PLoS ONE"},{"issue":"15","key":"4806_CR97","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1242\/jcs.00618","volume":"116","author":"M \u00c1lvarez","year":"2003","unstructured":"\u00c1lvarez M, Estivill X, de la Luna S (2003) DYRK1A accumulates in splicing speckles through a novel targeting signal and induces speckle disassembly. J Cell Sci 116(15):3099\u20133107","journal-title":"J Cell Sci"},{"issue":"02","key":"4806_CR98","first-page":"60","volume":"212","author":"H Kentrup","year":"2000","unstructured":"Kentrup H, Joost HG, Heimann G, Becker W (2000) Minibrain\/DYRK1A-gen: Kandidatengen f\u00fcr die mentaleRetardierungbeiDown-Syndrom? KlinischeP\u00e4diatrie 212(02):60\u201363","journal-title":"KlinischeP\u00e4diatrie"},{"issue":"1","key":"4806_CR99","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.nbd.2010.06.011","volume":"40","author":"D Toiber","year":"2010","unstructured":"Toiber D, Azkona G, Ben-Ari S, Tor\u00e1n N, Soreq H, Dierssen M (2010) Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations. Neurobiol Dis 40(1):348\u2013359","journal-title":"Neurobiol Dis"},{"issue":"2","key":"4806_CR100","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1742-4658.2010.07955.x","volume":"278","author":"J Wegiel","year":"2011","unstructured":"Wegiel J, Gong CX, Hwang YW (2011) The role of DYRK1A in neurodegenerative diseases. FEBS J 278(2):236\u2013245","journal-title":"FEBS J"},{"issue":"1","key":"4806_CR101","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/NEN.0b013e318202bfa1","volume":"70","author":"J Wegiel","year":"2011","unstructured":"Wegiel J, Kaczmarski W, Barua M, Kuchna I, Nowicki K, Wang KC, Wegiel J, Yang Ma S et al (2011) Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome. J Neuropathol Exp Neurol 70(1):36\u201350","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"4806_CR102","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/nn.3256","volume":"15","author":"HB Kwon","year":"2012","unstructured":"Kwon HB, Kozorovitskiy Y, Oh WJ, Peixoto RT, Akhtar N, Saulnier JL, Gu C, Sabatini BL (2012) Neuroligin-1\u2013dependent competition regulates cortical synaptogenesis and synapse number. Nat Neurosci 15(12):1667\u20131674","journal-title":"Nat Neurosci"},{"issue":"4","key":"4806_CR103","first-page":"1203","volume":"40","author":"J Gao","year":"2012","unstructured":"Gao J, Yang X, Yin P, Hu W, Liao H, Miao Z, Pan C, Li N (2012) The involvement of FoxO in cell survival and chemosensitivity mediated by Mirk\/Dyrk1B in ovarian cancer. Int J Oncol 40(4):1203\u20131209","journal-title":"Int J Oncol"},{"issue":"3","key":"4806_CR104","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1528-1167.2010.02916.x","volume":"52","author":"KH Jung","year":"2011","unstructured":"Jung KH, Chu K, Lee ST, Park KI, Kim JH, Kang KM, Kim S, Jeon D et al (2011) Molecular alterations underlying epileptogenesis after prolonged febrile seizure and modulation by erythropoietin. Epilepsia 52(3):541\u2013550","journal-title":"Epilepsia"},{"issue":"1","key":"4806_CR105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev.cellbio.20.010403.111746","volume":"20","author":"M Piper","year":"2004","unstructured":"Piper M, Holt C (2004) RNA translation in axons. Annu Rev Cell Dev Biol 20(1):505\u2013523","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"11","key":"4806_CR106","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1212\/01.WNL.0000129697.01779.0A","volume":"62","author":"P Tiraboschi","year":"2004","unstructured":"Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J (2004) The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology 62(11):1984\u20131989","journal-title":"Neurology"},{"key":"4806_CR107","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.bbadis.2009.09.008","volume":"1802","author":"J Gotz","year":"2010","unstructured":"Gotz J, Gladbach A, Pennanen L, van Eersel J, Schild A, David D, Ittner LM (2010) Animal models reveal role for tauphosphorylation in human disease. Biochim Biophys Acta Mol Basis Dis 1802:860\u2013871","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"4806_CR108","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/hmg\/ddl437","volume":"16","author":"R Kimura","year":"2007","unstructured":"Kimura R, Kamino K, Yamamoto M, Nuripa A, Kida T, Kazui H, Hashimoto R, Tanaka T et al (2007) The DYRK1A gene, encoded in chromosome 21 Down syndrome critical region, bridges between \u03b2-amyloid production and tau phosphorylation in Alzheimer disease. Hum Mol Genet 16(1):15\u201323","journal-title":"Hum Mol Genet"},{"issue":"22","key":"4806_CR109","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1021\/acs.jmedchem.8b00185","volume":"61","author":"DB Jarhad","year":"2018","unstructured":"Jarhad DB, Mashelkar KK, Kim HR, Noh M, Jeong LS (2018) Dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors as potential therapeutics. J Med Chem 61(22):9791\u20139810","journal-title":"J Med Chem"},{"issue":"194","key":"4806_CR110","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pharmthera.2018.09.010","volume":"1","author":"ML Arbones","year":"2019","unstructured":"Arbones ML, Thomazeau A, Nakano-Kobayashi A, Hagiwara M, Delabar JM (2019) DYRK1A and cognition: a lifelong relationship. Pharmacol Ther 1(194):199\u2013221","journal-title":"Pharmacol Ther"},{"issue":"1","key":"4806_CR111","doi-asserted-by":"crossref","first-page":"22460","DOI":"10.1038\/srep22460","volume":"6","author":"Y Wu","year":"2016","unstructured":"Wu Y, Zhang S, Xu Q, Zou H, Zhou W, Cai F, Li T, Song W (2016) Regulation of global gene expression and cell proliferation by APP. Sci Rep 6(1):22460","journal-title":"Sci Rep"},{"issue":"33","key":"4806_CR112","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1523\/JNEUROSCI.2551-21.2022","volume":"42","author":"IF Bessone","year":"2022","unstructured":"Bessone IF, Navarro J, Martinez E, Karmirian K, Holubiec M, Alloatti M, Goto-Silva L, Yepez CA et al (2022) DYRK1A regulates the bidirectional axonal transport of APP in human-derived neurons. J Neurosci 42(33):6344\u20136358","journal-title":"J Neurosci"},{"key":"4806_CR113","doi-asserted-by":"crossref","first-page":"9355","DOI":"10.3390\/ijms23169355","volume":"23","author":"E Deboever","year":"2022","unstructured":"Deboever E, Fistrovich A, Hulme C et al (2022) The omnipresence of DYRK1A in human diseases. Int J Mol Sci 23:9355","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4806_CR114","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41598-017-00682-y","volume":"7","author":"X Yin","year":"2017","unstructured":"Yin X, Jin N, Shi J, Zhang Y, Wu Y, Gong CX, Iqbal K, Liu F (2017) DYRK1A overexpression leads to increase of 3R-tau expression and cognitive deficits in Ts65Dn Down syndrome mice. Sci Rep 7(1):619","journal-title":"Sci Rep"},{"issue":"11","key":"4806_CR115","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3390\/genes12111833","volume":"12","author":"H Atas-Ozcan","year":"2021","unstructured":"Atas-Ozcan H, Brault V, Duchon A, Herault Y (2021) DYRK1A from gene function in development and physiology to dosage correction across life span in down syndrome. Genes 12(11):1833","journal-title":"Genes"},{"key":"4806_CR116","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1006\/geno.1999.5775","volume":"57","author":"J Guimera","year":"1999","unstructured":"Guimera J, Casas C, Estivill X, Pritchard M (1999) Human minibrain homologue (MNBH\/DYRK1): characterization, alternative splicing, differential tissue expression, and overexpression in Down syndrome. Genomics 57:407\u2013418","journal-title":"Genomics"},{"key":"4806_CR117","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2337\/dbi16-0013","volume":"65","author":"BF Belgardt","year":"2016","unstructured":"Belgardt BF, Lammert E (2016) DYRK1A: a promising drug target for islet transplant-based diabetes therapies. Diabetes 65:1496\u20131498","journal-title":"Diabetes"},{"key":"4806_CR118","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0006-8993(02)04069-6","volume":"964","author":"E Mart\u00ed","year":"2003","unstructured":"Mart\u00ed E, Altafaj X, Dierssen M, de La Luna S, Fotaki V, Alvarez M, P\u00e9rez-Riba M, Ferrer I et al (2003) DYRK1A expression pattern supports specific roles of this Kinase in the adult central nervous system. Brain Res 964:250\u2013263","journal-title":"Brain Res"},{"issue":"229","key":"4806_CR119","doi-asserted-by":"crossref","first-page":"114062","DOI":"10.1016\/j.ejmech.2021.114062","volume":"5","author":"T Liu","year":"2022","unstructured":"Liu T, Wang Y, Wang J, Ren C, Chen H, Zhang J (2022) DYRK1A inhibitors for disease therapy: currentstatus and perspectives. Eur J Med Chem 5(229):114062","journal-title":"Eur J Med Chem"},{"issue":"26","key":"4806_CR120","doi-asserted-by":"crossref","first-page":"8940","DOI":"10.1523\/JNEUROSCI.0026-12.2012","volume":"32","author":"CN Hall","year":"2012","unstructured":"Hall CN, Klein-Fl\u00fcgge MC, Howarth C, Attwell D (2012) Oxidative phosphorylation, not glycolysis, powers presynaptic and postsynaptic mechanisms underlying brain information processing. J Neurosci 32(26):8940\u20138951","journal-title":"J Neurosci"},{"issue":"133","key":"4806_CR121","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brainresbull.2016.08.009","volume":"1","author":"HM Wilkins","year":"2017","unstructured":"Wilkins HM, Swerdlow RH (2017) Amyloid precursor protein processing and bioenergetics. Brain Res Bull 1(133):71\u201379","journal-title":"Brain Res Bull"},{"issue":"16","key":"4806_CR122","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1093\/hmg\/ddu157","volume":"23","author":"A Izzo","year":"2014","unstructured":"Izzo A, Manco R, Bonfiglio F, Cal\u00ec G, De Cristofaro T, Patergnani S, Cicatiello R, Scrima R et al (2014) NRIP1\/RIP140 siRNA-mediated attenuation counteracts mitochondrial dysfunction in Down syndrome. Hum Mol Genet 23(16):4406\u20134419","journal-title":"Hum Mol Genet"},{"issue":"6","key":"4806_CR123","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ceb.2009.08.009","volume":"21","author":"R Kageyama","year":"2009","unstructured":"Kageyama R, Ohtsuka T, Shimojo H, Imayoshi I (2009) Dynamic regulation of Notch signaling in neural progenitor cells. Curr Opin Cell Biol 21(6):733\u2013740","journal-title":"Curr Opin Cell Biol"},{"issue":"1\u20132","key":"4806_CR124","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jns.2006.01.007","volume":"244","author":"MH Nagarsheth","year":"2006","unstructured":"Nagarsheth MH, Viehman A, Lippa SM, Lippa CF (2006) Notch-1 immunoexpression is increased in Alzheimer\u2019s and Pick\u2019s disease. J Neurol Sci 244(1\u20132):111\u2013116","journal-title":"J Neurol Sci"},{"issue":"6","key":"4806_CR125","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0165-6147(89)90263-0","volume":"10","author":"UT R\u00fcegg","year":"1989","unstructured":"R\u00fcegg UT, Gillian B (1989) Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol Sci 10(6):218\u2013220","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"4806_CR126","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/acel.12648","volume":"16","author":"C Branca","year":"2017","unstructured":"Branca C, Shaw DM, Belfiore R, Gokhale V, Shaw AY, Foley C, Smith B, Hulme C et al (2017) Dyrk1 inhibition improves Alzheimer\u2019s disease-like pathology. Aging Cell 16(5):1146\u20131154","journal-title":"Aging Cell"},{"issue":"5","key":"4806_CR127","doi-asserted-by":"crossref","first-page":"e13000","DOI":"10.1111\/acel.13000","volume":"18","author":"B Melchior","year":"2019","unstructured":"Melchior B, Mittapalli GK, Lai C, Duong-Polk K, Stewart J, G\u00fcner B, Hofilena B, Tjitro A et al (2019) Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: a potential therapeutic for Alzheimer\u2019s disease. Aging Cell 18(5):e13000","journal-title":"Aging Cell"},{"issue":"11","key":"4806_CR128","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.euroneuro.2015.03.018","volume":"25","author":"G Naert","year":"2015","unstructured":"Naert G, Ferr\u00e9 V, Meunier J, Keller E, Malmstr\u00f6m S, Givalois L, Carreaux F, Bazureau JP et al (2015) Leucettine L41, a DYRK1A-preferential DYRKs\/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric A\u03b225\u201335 peptide administration in mice. Eur Neuropsychopharmacol 25(11):2170\u201382","journal-title":"Eur Neuropsychopharmacol"},{"issue":"11","key":"4806_CR129","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3390\/ph14111170","volume":"14","author":"W Stensen","year":"2021","unstructured":"Stensen W, Rothweiler U, Engh RA, Stasko MR, Bederman I, Costa AC, Fugelli A, Svendsen JS (2021) Novel DYRK1A inhibitor rescues learning and memory deficits in a mouse model of Down syndrome. Pharmaceuticals 14(11):1170","journal-title":"Pharmaceuticals"},{"key":"4806_CR130","doi-asserted-by":"crossref","first-page":"109525","DOI":"10.1016\/j.neuropharm.2023.109525","volume":"232","author":"X Liu","year":"2023","unstructured":"Liu X, Lai LY, Chen JX, Li X, Wang N, Zhou LJ, Jiang XW, Hu XL et al (2023) An inhibitor with GSK3\u03b2 and DYRK1A dual inhibitory properties reduces tau hyperphosphorylation and ameliorates disease in models of Alzheimer\u2019s disease. Neuropharmacology 232:109525","journal-title":"Neuropharmacology"},{"key":"4806_CR131","first-page":"100193","volume":"27","author":"VA Bakalakou","year":"2024","unstructured":"Bakalakou VA, Mavroidi B, Kalampaliki AD, Josselin B, Bach S, Skaltsounis AL, Marakos P, Pouli N et al (2024) The pyrazolo [4, 3-c] pyrazole core as a novel and versatile scaffold for developing dual DYRK1A-CLK1 inhibitors targeting key processes of Alzheimer\u2019s disease pathology. Eur J Med Chem Rep 27:100193","journal-title":"Eur J Med Chem Rep"},{"issue":"20","key":"4806_CR132","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1021\/om400359m","volume":"32","author":"J Amin","year":"2013","unstructured":"Amin J, Chuckowree IS, Wang M, Tizzard GJ, Coles SJ, Spencer J (2013) Synthesis of oxindole-based bioorganometallic kinase inhibitors incorporating one or more ferrocene groups. Organometallics 32(20):5818\u20135825","journal-title":"Organometallics"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04806-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04806-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04806-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T11:03:55Z","timestamp":1751627035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04806-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":132,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["4806"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04806-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"17 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}